Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Enrico Barbato"'
Autor:
Giovanni Micallo, Enrico Barbato, Massimo Cirillo, Editta Baldini, Alfredo Tartarone, Elisabetta Cretella, Luciano Carlucci, Vanna Maria Valori, Giuseppe Tonini, Francesco Carrozza, Maria Luisa Meacci, Teresa Gamucci, Stefania Gori, Valentina Fabbroni, Vittorina Zagonel, Carmine Pinto, Daniele Farci, Saverio Cinieri, Marta Zaninelli, Cosimo Sacco, Gianluigi Lunardi, Lorenzo Legramandi, Silvana Leo, Stefano Cascinu, Giampaolo Tortora, Sonia Zamboni, Francesca Di Fabio
Publikováno v:
Journal of clinical nursingREFERENCES. 29(1-2)
Aims and objectives To assess the effectiveness of a specific home care nursing programme in addition to standard care in patients (pts) receiving oral anticancer treatments. Background Oral anticancer therapy present challenges for pts since treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0862d3664dd0f120b381f1db337dae96
https://pubmed.ncbi.nlm.nih.gov/31532035
https://pubmed.ncbi.nlm.nih.gov/31532035
Autor:
Enrico Barbato, Maria Teresa Ionta, Donato Natale, Livio Blasi, Liberato Di Lullo, Giuseppe Barberis, Rossana Casaretti, S. Mancarella, Vincenzo Formica, Bruno Massidda, Giacomo Vessia, Ettore Greco, Gianfranco Filippelli, Mario Roselli, Luigi Maiorino, Anna Russo
Early switching to de-intensified maintenance regimen is still a matter of debate in metastatic colorectal cancer (mCRC). The MARTHA trial, a S.I.C.O.G. phase III randomized trial, compared FOLOFIRI+bevacizumab (B) for 12 cycles (6 months) followed b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec1c2902f3e8ea997fb1c7182e0a0dc4
http://hdl.handle.net/2108/194507
http://hdl.handle.net/2108/194507
Autor:
Vincenzo, Formica, Maria Teresa, Ionta, Bruno, Massidda, Giacomo, Vessia, Luigi, Maiorino, Rossana, Casaretti, Donato, Natale, Giuseppe, Barberis, Gianfranco, Filippelli, Ettore, Greco, Livio, Blasi, Sergio, Mancarella, Anna, Russo, Enrico, Barbato, Liberato Di, Lullo, Mario, Roselli
Publikováno v:
Oncotarget
Early switching to de-intensified maintenance regimen is still a matter of debate in metastatic colorectal cancer (mCRC). The MARTHA trial, a S.I.C.O.G. phase III randomized trial, compared FOLOFIRI+bevacizumab (B) for 12 cycles (6 months) followed b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::735325866accfa6150196c287317f822
https://pubmed.ncbi.nlm.nih.gov/29416820
https://pubmed.ncbi.nlm.nih.gov/29416820
Autor:
Antonio Gambardella, G. Condemi, Antonio Avallone, Carlo Putzu, Giuseppe De Cataldis, Enrico Barbato, Luca Franco, Bruno Massidda, Pasquale Comella
Publikováno v:
Lung Cancer. 56:263-271
Summary Purpose This study was undertaken to select the best schedule of administration for the paclitaxel plus gemcitabine combination in fit elderly patients affected by locally advanced or metastatic non-small cell lung cancer (NSCLC). Patients an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c2778b3a606f644c568407071bc0d09
https://doi.org/10.1016/j.lungcan.2006.12.015
https://doi.org/10.1016/j.lungcan.2006.12.015
Autor:
Enrico Barbato, Luigi Maiorino, Maria Teresa Ionta, Ettore Greco, Vincenzo Formica, Giuseppe Barberis, Liberato Di Lullo, Livio Blasi, Anna Russo, S. Mancarella, Rossana Casaretti, Vessia Giacomo, Gianfranco Filippelli, Mario Roselli, Donato Natale
Publikováno v:
Journal of Clinical Oncology. 35:3552-3552
3552 Background: FOLFIRI+bevacizuamab(B) is a standard first-line regimen for mCRC pts. It should be delivered until progression, though an early switch to a de-intensified maintenance regimen is often adopted because of toxicity. The MARTHA trial co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9be414ec6c0074409f74ff706acb24aa
https://doi.org/10.1200/jco.2017.35.15_suppl.3552
https://doi.org/10.1200/jco.2017.35.15_suppl.3552
Autor:
Enrico Barbato, Vincenzo Montesarchio, Agata Pisano, Michelino De Laurentiis, Fortunato Ciardiello, Geppino Genua, Roberta Caputo, Ferdinando Riccardi, Adriano Gravina, Maria Luisa Barzelloni, Giuseppe Grimaldi, Carmela Mocerino, Raffaele Nettuno, A. Diana, Alessio Fabozzi, Pasquale Incoronato, Luigi Leopaldi, Giovanni Iodice, Guido Giordano, Michele Orditura, E. Procaccini, Roberto Mabilia, Antonio Febbraro, Eva Lieto
Publikováno v:
ESMO Open
Background On the basis of the results of two pivotal phase III clinical trials, eribulin mesylate is currently approved in EU for the treatment of advanced breast cancer (aBC) in patients who have previously received an anthracycline and a taxane in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02c599fcccc8d6ec383f496c2151633b
https://doi.org/10.1136/esmoopen-2017-000176
https://doi.org/10.1136/esmoopen-2017-000176
Autor:
Raffaele Addeo, Gabriella Misso, Riccardo Tonachella, Gianfranco Filippelli, Agata Pisano, Giuseppe Pistolese, Gregorio Cennamo, Ferdinando Riccardi, Luigi Leo, Roberto Mabilia, Enrico Barbato, Saverio Cinieri, Luigi Maiorino, M. Bianco, Salvatore Palazzo, Antonio Febbraro, Bruno Vincenzi, Luigi Manzione, C. Pizza, Clementina Savastano, Michele Caraglia, Vito Lorusso, Vincenzo Montesarchio, Salvatore Del Prete
ABSTRACT: Aim: We investigated the role of erythropoietin (EPO) in reducing anemia and preventing the development of psychological distress in patients treated with chemotherapy. Patients & methods: This prospective observational study enrolled 591 a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38738d5de4cc7bf6a52e2343b23c77b3
http://hdl.handle.net/11591/184106
http://hdl.handle.net/11591/184106
Autor:
Antonio Febbraro, Gregorio Cennamo, Giancarlo Filippelli, Clementina Savastano, Vincenzo Montesarchio, M. Bianco, Bruno Vincenzi, Vito Lorusso, Nicola Lambiase, Enrico Barbato, Francesco Giotta, Luigi Leo, Carmine Pizza, Vittorio Gebbia, Luigi Maiorino, Luigi Manzione, Salvatore Del Prete, Roberto Mabilia, Saverio Cinieri, Agata Pisano, Giuseppe Pistolese, Raffaele Addeo
Publikováno v:
European Journal of Cancer Supplements. 6(14)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1da707083a365a870db8abf303f7a575
Autor:
Pasquale, Comella, Carlo, Putzu, Bruno, Massidda, Giovanni, Condemi, Giuseppe, De Cataldis, Enrico, Barbato, Antonio, Gambardella, Antonio, Avallone, Luca, Franco
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 56(2)
This study was undertaken to select the best schedule of administration for the paclitaxel plus gemcitabine combination in fit elderly patients affected by locally advanced or metastatic non-small cell lung cancer (NSCLC).Ninety-eight patients in sta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eee5ba280e3767437fafc35e65a99d12
https://pubmed.ncbi.nlm.nih.gov/17298853
https://pubmed.ncbi.nlm.nih.gov/17298853
Autor:
Pasquale Cornella, Antonio Farris, Cosimo Brunetti, N. Panza, Enrico Barbato, Marina Licenziato, Dario Muci, Giuseppe Frasci, Giuseppe Comella, Luigi Maiorino
Publikováno v:
Lung Cancer. 41:S231
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0b1726af3e0a28ba807f81601947b5a
https://doi.org/10.1016/s0169-5002(03)92522-0
https://doi.org/10.1016/s0169-5002(03)92522-0